@ciccancer.bsky.social @csic.es @usaloficial.bsky.social @contracancerinv.bsky.social @ageinves.bsky.social
@ciccancer.bsky.social @csic.es @usaloficial.bsky.social @contracancerinv.bsky.social @ageinves.bsky.social
This research was supported by the Agencia Estatal de Investigación/Ministerio de Ciencia, Innovación y Universidades, the Scientific Foundation of the Spanish Association Against Cancer, Instituto de Salud Carlos III, Comunidad de Madrid and the European Research Council.
Restoration of Capicua repressor activity or silencing of Capicua target genes ETV4 and ETV5 restores the sensitivity to trametinib. In addition, absence of Capicua creates new vulnerabilities that can be exploited to overcome resistance.
We show that absence of Capicua suppresses the requirement for Kras oncogene amplification during lung tumor development, leading to more efficient transformation of bronchiolar Club cells and resistance to MAPK pathway inhibitors.
Happy to share our article published in @embomolmed.org in which we demonstrate that the repressor Capicua acts as a natural barrier to lung tumor development driven by Kras/Trp53 mutations. You can read it here: www.embopress.org/doi/full/10....
EACR Board members and other key opinion leaders author regular EACR Viewpoint articles in our affiliated journal, @moloncology.bsky.social
'The rapidly growing landscape of RAS inhibitors: from selective allele blockade to broad inhibition strategies': febs.onlinelibrary.wiley.com/doi/10.1002/...
The repressor #Capicua is a barrier to #LungTumor development driven by Kras/Trp53 mutations 👉 doi.org/10.1038/s443...
By I. Ballesteros-González, @matthiasdrosten.bsky.social & colleagues @ciberisciii.bsky.social @ciccancer.bsky.social
Happy to share our EACR Viewpoint published in @moloncology.bsky.social
⏳ The countdown is on: 2 weeks to go!
In just 14 days, Salamanca will host #TargetingRAS2025, a symposium uniting researchers and industry leaders to push the boundaries of RAS biology.
💡 Have you checked your registration and planned your trip? We can’t wait to welcome you!
#25anniversaryCIC
🔍 What to expect at #TargetingRAS2025?
From Oct 8–10, Salamanca will unite world-class scientists, young researchers & industry leaders to explore the latest in RAS biology.
✨ Highlights: Keynotes, KRAS sessions, posters, Short Talks & networking.
📅 Get ready for 3 days of cutting-edge science!
⏳ The countdown is on! Only a few days left to benefit from the Early Bird registration rates for Targeting RAS 2025.
🔹 Students & Postdocs: €150
🔹 Academia & Non-profit: €250
🔹 Industry: €500
👉 https://targetingras.com/registration/
#TargetingRAS2025 #EarlyBird #CancerResearch #25anniversaryCIC
📢 Early Bird registration for Targeting RAS 2025 closes in just one month — on August 31st!
🧬 Join now the international RAS community in Salamanca and benefit from discounted access.
🔗 Register now: https://targetingras.com/registration
#TargetingRAS2025 #EarlyBird #CancerResearch #RASBiology
🎤 Meet Our Speaker: Dr. Mark Pearson, from @boehringerglobal.bsky.social (Germany) as a speaker at the Targeting RAS Symposium 2025.
Dr. Pearson will give his talk during Session 7 on Day 2 at 16:30h.
🔗 Register now: https://targetingras.com/registration/
#TargetingRAS2025 #25anniversaryCIC
🚨 Abstract Submission Deadline Approaching! 🚨
Don’t miss your chance to be part of Targeting RAS 2025 — a premier symposium bringing together the world’s leading experts in RAS research.
🔗 targetingras.com/abstract-pos...
🎤 Meet Dr. Kevan Shokat, from University of California (San Francisco, USA) as a speaker at the Targeting RAS Symposium 2025.
Dr. Shokat will kick off Session 6 on Day 2 with his talk at 11:30h.
🔗 Register now: https://targetingras.com/registration/
#TargetingRAS2025 #25anniversaryCIC
🎤 Meet Dr. Andy Aguirre, from @danafarber.bsky.social and @harvardmed.bsky.social (Boston, USA) as a speaker at the Targeting RAS Symposium 2025.
Dr. Aguirre will give his talk during Session 3 on Day 1 at 15:30h
🔗 https://targetingras.com/registration/
#TargetingRAS2025 #25anniversaryCIC
🔔 We remind you that registration is OPEN for Targeting RAS 2025 ‼️
🧬 Join us in Salamanca from October 8–10 for one of the leading scientific meetings on RAS biology and cancer research.
🌐 Register now: targetingras.com/registration/
(1/4)
🔗 Science thrives on connections!
🗨️ At the Targeting RAS Symposium 2025, networking opportunities are an essential part of the experience. The programme has been designed in order to propitiate the exchange of ideas between young talent and established researchers.
🏛 Why Salamanca? A Hub for Scientific Excellence
A city renowned for its academic prestige and scientific innovation, is the ideal host for Targeting RAS Symposium 2025. Home to one of the oldest universities, it has long been a center for groundbreaking research and international collaboration.
(1/5)
🔍 Why RAS Research Matters?
RAS proteins play a pivotal role in cancer development, making them a critical focus in biomedical research. Understanding their mechanisms can unlock new therapeutic strategies and improve patient outcomes.
#TargetingRAS2025 #25anniversaryCIC
🎤 Meet Dr. Piro Lito (Memorial Sloan Kettering, NY)
He’ll open Session 1 at #TargetingRAS2025 with his talk on Oct 8 at 9:00 AM 🧠🔥
🗣️ Don’t miss this chance to learn from one of the top voices in the field!
📍Salamanca | 📅 Oct 8–10
🔗 Register: https://targetingras.com/registration/
#Speaker #RAS
1/5
🔬 Meet the Organizing Committee for the Targeting RAS Symposium 2025! A distinguished Organizing Committee of leading researchers and experts is shaping an event dedicated to cutting-edge advances in RAS-driven cancers.
#TargetingRAS2025
(1/4)
🚀 We are thrilled to announce the 2nd Targeting RAS Symposium!
🎯 Join us Oct 8-10, 2025, at Palacio de Congresos, Salamanca, Spain.
@molinaarcas.bsky.social @drcolinlindsay.bsky.social
🚀 We are thrilled to announce the second edition of the Targeting RAS Symposium! 🎯🔬
📆 October 8-10, 2025
📍 Palacio de Congresos, Salamanca, Spain
🌐 Our website is now live! Register and join the conversation: targetingras.com